136 related articles for article (PubMed ID: 7921730)
21. [Associated psychotropic drugs in deficit schizophrenia].
Beaufils B
Encephale; 1996 Jun; 22 Spec No 2():41-3. PubMed ID: 8767041
[TBL] [Abstract][Full Text] [Related]
22. Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs.
Mauri MC; Moliterno D; Rossattini M; Colasanti A
Schizophr Res; 2008 Feb; 99(1-3):7-12. PubMed ID: 18055177
[TBL] [Abstract][Full Text] [Related]
23. Negative symptoms in nondeficit syndrome respond to neuroleptic treatment with changes in plasma homovanillic acid concentrations.
Suzuki E; Kanba S; Koshikawa H; Nibuya M; Yagi G; Asai M
J Psychiatry Neurosci; 1996 May; 21(3):167-71. PubMed ID: 8935328
[TBL] [Abstract][Full Text] [Related]
24. Psychopharmacologic treatment of negative schizophrenic symptoms.
Opler LA; Albert D; Ramirez PM
Compr Psychiatry; 1994; 35(1):16-28. PubMed ID: 7908618
[TBL] [Abstract][Full Text] [Related]
25. [Comparative effectiveness of flupenthixol and risperidone on negative symptoms of schizophrenia].
Philipp M; Lesch OM; Schmauss M; Dose M; Glaser T
Psychiatr Prax; 2003 May; 30 Suppl 2():S94-6. PubMed ID: 14509050
[TBL] [Abstract][Full Text] [Related]
26. Understanding schizophrenia: the impact of novel antipsychotics.
Remington G
Can J Psychiatry; 1995 Sep; 40(7 Suppl 2):S29-32. PubMed ID: 8564914
[No Abstract] [Full Text] [Related]
27. [Resistant schizophrenia: what chemotherapy?].
Vanelle JM
Ann Med Psychol (Paris); 1993 Apr; 151(4):346-51. PubMed ID: 7904434
[No Abstract] [Full Text] [Related]
28. Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis.
Singh SP; Singh V; Kar N; Chan K
Br J Psychiatry; 2010 Sep; 197(3):174-9. PubMed ID: 20807960
[TBL] [Abstract][Full Text] [Related]
29. [Deficit: the value and difficulty of defining the primary or secondary character of observed symptoms].
Petit M; Langlois S
Encephale; 1996 Jun; 22 Spec No 2():13-8. PubMed ID: 8767036
[TBL] [Abstract][Full Text] [Related]
30. Management of treatment refractory schizophrenia.
Morrison DP
Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
[No Abstract] [Full Text] [Related]
31. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
Chiu H; Lau J; Lam L; Shum P
Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
[TBL] [Abstract][Full Text] [Related]
32. Antidepressant usage in schizophrenia.
Plasky P
Schizophr Bull; 1991; 17(4):649-57. PubMed ID: 1687176
[TBL] [Abstract][Full Text] [Related]
33. Improvement of negative symptoms: Concepts, definition and assessment.
Andreasen NC
Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S7-10. PubMed ID: 9218162
[TBL] [Abstract][Full Text] [Related]
34. Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine.
Friedman J; Ault K; Powchik P
Biol Psychiatry; 1997 Sep; 42(6):522-3. PubMed ID: 9285089
[No Abstract] [Full Text] [Related]
35. An open study of buspirone augmentation of neuroleptics in patients with schizophrenia.
Sirota P; Epstein B; Benatov R; Sousnostzky M; Kindler S
J Clin Psychopharmacol; 2001 Aug; 21(4):454-5. PubMed ID: 11476132
[No Abstract] [Full Text] [Related]
36. "Revealed" Depression and drug treatment for schizophrenia.
Knights A; Hirsch SR
Arch Gen Psychiatry; 1981 Jul; 38(7):806-11. PubMed ID: 6113822
[TBL] [Abstract][Full Text] [Related]
37. The Relevance of Negative Symptoms in Schizophrenia and How to Treat Them with Psychopharmaceuticals?
Möller HJ
Psychiatr Danub; 2016 Dec; 28(4):435-440. PubMed ID: 27855437
[TBL] [Abstract][Full Text] [Related]
38. [Profile of the action of neuroleptics in deficit schizophrenia].
Vanelle JM
Encephale; 1996 Jun; 22 Spec No 2():33-9. PubMed ID: 8767040
[TBL] [Abstract][Full Text] [Related]
39. Factors which can make patients difficult to treat.
Kane JM
Br J Psychiatry Suppl; 1996 Dec; (31):10-4. PubMed ID: 8968650
[No Abstract] [Full Text] [Related]
40. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
Kopala LC; Fredrikson D; Good KP; Honer WG
Biol Psychiatry; 1996 Feb; 39(4):296-8. PubMed ID: 8645777
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]